Cardiac Amyloidosis: What Heart Failure Clinicians Need to Know

Educational Activity

Faculty Listing


Angela Dispenzieri, MD

Professor of Medicine

Consultant – Division of Hematology

Research Chair – Division of Hematology

Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine and Pathology

Mayo Clinic, Rochester, MN


Daniel P Judge, MD, FHFSA

Professor of Medicine/Cardiology

Director of Cardiovascular Genetics

Fellowship Program Director for Cardiology

Medical University of South Carolina

Charleston, SC


Richard Cheng, MD, MSc

Associate Professor of Cardiology and Radiology (Adjunct)

Program Director, Advanced Heart Failure and Transplant Fellowship

Director, Cardio-oncology Program

Co-director, UW/SCCA Amyloidosis Program

University of Washington

Seattle, WA


Margaret Cuomo, MS, FNP-C

Center for Advanced Cardiac Care

Columbia University Irving Medical Center

New York, NY


Faculty Disclosures


In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.


Any person who may contribute to the content of this continuing educa­tion activity must disclose relevant relationships (and any known relation­ships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial inter­est is defined as any entity producing, marketing, re-selling, or distribut­ing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grant, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.


Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with infor­mation that might be of potential importance to their evaluation of a presentation.


Mazen Hanna, MD

Disclosure: Consultant-Advisory Board: Pfizer; AKCEA; Alynlam; and Eidos Therapeutics


Angela Dispenzieri, MD

Disclosure: Nothing to Disclose


Daniel P. Judge, MD, FHFSA

Disclosure: Consultant-Advisory Board: Pfizer; ADRx, Inc; Tenaya Therapeutics; and Cytokinetics


Richard Cheng, MD, MSc

Disclosure: Nothing to Disclose


Margaret Cuomo, MS, FNP-C

Disclosure: Nothing to Disclose

Powered by Oasis.